Single course versus maintenance bacillus Calmette-Guerin therapy for superficial bladder tumors: a prospective, randomized trial.

M. A. Hudson*, T. L. Ratliff, D. P. Gillen, E. O. Haaff, S. M. Dresner, W. J. Catalona

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

108 Scopus citations

Abstract

A total of 42 patients with recurrent superficial bladder tumors or carcinoma in situ entered a prospective, randomized trial to compare the efficacy of bacillus Calmette-Guerin therapy with and without quarterly maintenance instillations of bacillus Calmette-Guerin. Maintenance therapy did not reduce further bladder tumor recurrence rates or the interval to recurrence in patients who responded to the initial course of therapy. However, prolongation of toxicity was observed with maintenance bacillus Calmette-Guerin therapy.

Original languageEnglish (US)
Pages (from-to)295-298
Number of pages4
JournalThe Journal of urology
Volume138
Issue number2
DOIs
StatePublished - Aug 1987

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Single course versus maintenance bacillus Calmette-Guerin therapy for superficial bladder tumors: a prospective, randomized trial.'. Together they form a unique fingerprint.

Cite this